Investigator identification
Investigator identification and unique site management solutions
Our robust feasibility findings and strong Investigator network helps us to identify the right site for the right study. We have a database of leading KOLs and investigators across all therapeutic areas in India who are ICH-GCP trained and have worked with our teams in the past. This helps us to target most potential sites based on their past working experience and training. In India, we also have the unique option of deploying trained CRCs at the investigational site to assist the study team at the site. These CRCs are trained by PhaseOn before the start of the study on project specific requirements and are based at the site.
Generic drug development
Generic drug development includes conducting Patient PK endpoint studies and also provide support to generic companies for the independent monitoring of the typical BA/BE studies.
Read More →
Quality Assurance
Offers access to highly experienced Quality Assurance personnel to ensure compliance and quality in all clinical studies. We also provide standalone QA and audit support services to clients as needed..
Read More →
Investigator Identification
PhaseOn leverages robust feasibility data and a trusted network of ICH-GCP trained KOLs and investigators across India to ensure accurate site selection across therapeutic areas.
Read More→